CRO News
Biofidelity and CellCarta Partner to Bring Aspyre Lung to Global Clinical Trials
Biofidelity, a company specialising in innovative genomic solutions, has partnered with CellCarta, a global contract research organisation (CRO), to integrate the Aspyre Lung platform into clinical trials worldwide. The partnership seeks to enhance the detection of NSCLC biomarkers, expediting clinical
10 January 2025